Skip to main content
. 2023 Dec 7;12(24):21742–21750. doi: 10.1002/cam4.6738

FIGURE 4.

FIGURE 4

Kaplan–Meier analyses for RFS (A) and OS (B) based on postoperative immunotherapy. (A) RFS in the AC group versus the AC + IM group in patients with positive lymph node metastasis; (B) OS in the AC group versus the AC + IM group in patients with positive lymph node metastasis. AC, adjuvant chemotherapy; AC + IM, combined adjuvant chemotherapy and immunotherapy; OS, overall survival; RFS, relapse‐free survival.